Serotonin receptor 6 (5-hydroxytrypamine-6, or 5-HT6) is a potential therapeutic target given its distribution in brain regions that are important in depression, anxiety, and cognition. This study sought to investigate the effects of age on 5-HT6 receptor availability using 11C-GSK215083, a PET ligand with affinity for 5-HT6 in the striatum and 5-HT2A in the cortex. Methods: Twenty-eight healthy male volunteers (age range, 23-52 y) were scanned with 11C-GSK215083 PET. Time-activity curves in regions of interest were fitted using a multilinear analysis method. Nondisplaceable binding potential (BPND) was calculated using the cerebellum as the reference region and corrected for partial-volume effects. Results: In 5-HT6-rich areas, regional 11C-GSK215083 showed a negative correlation between BPND and age in the caudate (r = -0.41, P = 0.03) (14% change per decade) and putamen (r = -0.30, P = 0.04) (11% change per decade) but not in the ventral striatum or pallidum. A negative correlation with age was also seen in cortical regions (r = -0.41, P = 0.03) (7% change per decade), consistent with the literature on 5-HT2A availability. Conclusion: To our knowledge, this was the first in vivo study on humans to examine the effect of age on 5-HT6 receptor availability. The study demonstrated a significant age-related decline in 5-HT6 availability (BPND) in the caudate and putamen.
Serotonin receptor 6 (5-hydroxytrypamine-6, or 5-HT6) is a potential therapeutic target given its distribution in brain regions that are important in depression, anxiety, and cognition. This study sought to investigate the effects of age on 5-HT6 receptor availability using 11C-GSK215083, a PET ligand with affinity for 5-HT6 in the striatum and 5-HT2A in the cortex. Methods: Twenty-eight healthy male volunteers (age range, 23-52 y) were scanned with 11C-GSK215083 PET. Time-activity curves in regions of interest were fitted using a multilinear analysis method. Nondisplaceable binding potential (BPND) was calculated using the cerebellum as the reference region and corrected for partial-volume effects. Results: In 5-HT6-rich areas, regional 11C-GSK215083 showed a negative correlation between BPND and age in the caudate (r = -0.41, P = 0.03) (14% change per decade) and putamen (r = -0.30, P = 0.04) (11% change per decade) but not in the ventral striatum or pallidum. A negative correlation with age was also seen in cortical regions (r = -0.41, P = 0.03) (7% change per decade), consistent with the literature on 5-HT2A availability. Conclusion: To our knowledge, this was the first in vivo study on humans to examine the effect of age on 5-HT6 receptor availability. The study demonstrated a significant age-related decline in 5-HT6 availability (BPND) in the caudate and putamen.
Authors: O Mawlawi; D Martinez; M Slifstein; A Broft; R Chatterjee; D R Hwang; Y Huang; N Simpson; K Ngo; R Van Heertum; M Laruelle Journal: J Cereb Blood Flow Metab Date: 2001-09 Impact factor: 6.200
Authors: Eydie L Moses-Kolko; Julie C Price; Nilesh Shah; Sarah Berga; Susan M Sereika; Patrick M Fisher; Rhaven Coleman; Carl Becker; N Scott Mason; Tammy Loucks; Carolyn C Meltzer Journal: Neuropsychopharmacology Date: 2011-08-17 Impact factor: 7.853
Authors: Jennifer C Roberts; Charlie Reavill; Simon Z East; Paul J Harrison; Sara Patel; Carol Routledge; Ronald A Leslie Journal: Brain Res Date: 2002-04-26 Impact factor: 3.252
Authors: Christine A Parker; Eugenii A Rabiner; Roger N Gunn; Graham Searle; Laurent Martarello; Robert A Comley; Maria Davy; Alan A Wilson; Sylvain Houle; Romina Mizrahi; Marc Laruelle; Vincent J Cunningham Journal: J Nucl Med Date: 2015-09-17 Impact factor: 10.057
Authors: Edward C Gaiser; Jean-Dominique Gallezot; Patrick D Worhunsky; Ania M Jastreboff; Brian Pittman; Lauren Kantrovitz; Gustavo A Angarita; Kelly P Cosgrove; Marc N Potenza; Robert T Malison; Richard E Carson; David Matuskey Journal: Neuropsychopharmacology Date: 2016-07-04 Impact factor: 7.853
Authors: Monika Marcinkowska; Adam Bucki; Joanna Sniecikowska; Agnieszka Zagórska; Nikola Fajkis-Zajączkowska; Agata Siwek; Monika Gluch-Lutwin; Paweł Żmudzki; Magdalena Jastrzebska-Wiesek; Anna Partyka; Anna Wesołowska; Michał Abram; Katarzyna Przejczowska-Pomierny; Agnieszka Cios; Elżbieta Wyska; Kamil Mika; Magdalena Kotańska; Paweł Mierzejewski; Marcin Kolaczkowski Journal: J Med Chem Date: 2021-08-26 Impact factor: 7.446
Authors: Justine Y Hansen; Golia Shafiei; Jacob W Vogel; Kelly Smart; Carrie E Bearden; Martine Hoogman; Barbara Franke; Daan van Rooij; Jan Buitelaar; Carrie R McDonald; Sanjay M Sisodiya; Lianne Schmaal; Dick J Veltman; Odile A van den Heuvel; Dan J Stein; Theo G M van Erp; Christopher R K Ching; Ole A Andreassen; Tomas Hajek; Nils Opel; Gemma Modinos; André Aleman; Ysbrand van der Werf; Neda Jahanshad; Sophia I Thomopoulos; Paul M Thompson; Richard E Carson; Alain Dagher; Bratislav Misic Journal: Nat Commun Date: 2022-08-10 Impact factor: 17.694
Authors: David Matuskey; Sule Tinaz; Kyle C Wilcox; Mika Naganawa; Takuya Toyonaga; Mark Dias; Shannan Henry; Brian Pittman; Jim Ropchan; Nabeel Nabulsi; Ivonne Suridjan; Robert A Comley; Yiyun Huang; Sjoerd J Finnema; Richard E Carson Journal: Ann Neurol Date: 2020-02-05 Impact factor: 10.422